Scientific fraud: Is prosecution the answer?

Despite a handful of recent criminal charges against researchers, experts say more legal action could hurt science

Written byAlison McCook
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
Now-disgraced stem cell researcher Woo-Suk Hwang is facing criminal charges from the Korean government after fabricating data, and another American researcher, Eric Poehlman, could receive jail time for fabricating data in 17 applications for US federal grants. Still, experts say that criminal charges against scientists have likely not increased. And if fraud prosecution increases, it could cause more harm than good.It remains unclear how authorities will handle the case of Jon Sudbo, a Norwegian cancer researcher who recently admitted to fabricating data from 900 patients in an NIH-funded 2005 Lancet paper linking use of non-steroidal anti-inflammatory drugs (NSAIDs) with a lower risk of oral cancer. Alan Price, associate director for investigative oversight at the US Office of Research Integrity (ORI) in Rockville, Md., told The Scientist that the ORI cannot comment on the Sudbo case, or whether he will face criminal charges.Price noted that criminal charges are filed in only "a couple tenths of a percent" of cases of scientific fraud, and this rate does not appear to be increasing. However, criminal charges "are so rare, that it's really hard to make a pattern," he said.He noted that the U.S. attorney decided to pursue Poehlman after he sued to block the University of Vermont from providing the federal government with information, a requirement of investigations into scientific misconduct. In general, U.S. attorneys "don't pursue" criminal charges against scientists, Price noted, because the investigations are very expensive, and prosecutors interested in healthcare have the potential to bring in significantly more money pursuing Medicare and Medicaid fraud, since those cases often end with large awards to the government.The Scientist contacted the offices of the state attorney generals in Maryland, New York and Pennsylvania, all of whom said they do not pursue criminal charges in cases of scientific misconduct."People who perpetrate scientific fraud generally believe they're going to get away with it, just the way people who rob banks think they're going to get away with it," said Jerome Kassirer of Tufts University in Boston, Ma., and former editor of the New England Journal of Medicine. Being ostracized by the scientific community once the fraud is discovered is a "bad enough" punishment, Kassirer told The Scientist.Scott Burris, a Temple University law professor who's studied public health, noted that prosecuting fraud could have a "chilling effect" on science. The vast majority of scientists are law-abiding, but seeing their colleagues facing criminal charges may cause some honest researchers to shy away from studying unpopular or controversial areas, fearing a mistake could land them in jail, Burris told The Scientist. "We shouldn't just assume that there's no cost to getting tough on research."However, Kassirer noted that criminal charges are warranted in many cases of scientific fraud-charges related to the misuse of federal funds, or endangering public health by influencing physicians' practices with their patients.Temple's Burris agreed that it's important to prosecute "bad actors"-meaning, people who commit repeated, and egregious, acts of misconduct. But given that most researchers are honest, it's unnecessary to slap every investigator accused of fraud with criminal charges, he said. "I don't think that's good for science, it's not good for justice, and it's not that great for the public purse."Editor's Note: What are journals doing to prevent fraud? See a related story.Alison McCook amccook@the-scientist.comLinks within this articleI. Oransky, "All Hwang human cloning work fraudulent," The Scientist, January 10, 2006. http://www.the-scientist.com/news/display/22933/D. Payne, "Researcher's faked data leads to lifetime ban on US grants," The Scientist, April 11, 2005. http://www.the-scientist.com/article/display/15409/S. Pincock, "Lancet study faked," The Scientist, January 16, 2006. http://www.the-scientist.com/news/display/22952/A.McCook, "Research's scarlet list," The Scientist, April 25, 2005. http://www.the-scientist.com/article/display/15418/PHS Administrative Actions Listing http://silk.nih.gov/public/cbz1bje.@www.orilist.htmlJerome Kassirer http://www.utmb.edu/healthpolicy/kassirer.htmScott Burris http://www.law.temple.edu/servlet/RetrievePage?site=TempleLaw&page=Faculty_BurrisD. Monroe, "Detecting fraud at journals," The Scientist, February 10, 2005. http://www.the-scientist.com/news/display/23107
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform